Friday, November 23, 2007

BioMS Medical

BioMS Medical
http://www.biomsmedical.com/
Video
http://www.wallstreetreporter.com./page.php?page=view_videos&id=122

Wall Street Reporter Features Exclusive Video Interviews with ...
CNNMoney.com - USA
The only Phase III study with a novel therapeutic for Secondary Progressive Multiple Sclerosis in the world. * The large patient population and lack of ...
See all stories on this topic

BioMS Medical Corp.
TSX: MS

Interview with:
Kevin Giese
President and Chief Executive Officer


Add to your social bookmarks : Bookmark to: WallStreetReporter.com Yahoo Bookmark to: WallStreetReporter.com Google Bookmark to: WallStreetReporter.com Del.ico.us Bookmark to: WallStreetReporter.com Digg
Digg! Save to My Web Technorati blog directory


• Reviews/Comments
There are no comments on this interview, be the first to post a comment.
• Corporate Info
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical’s lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01.

Company Website

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Historical


Symbol: Symbol Lookup powered by
quotemedia.com
Detailed Quote for Bioms Medical (MS:CA)
$ 2.35 0.09 (+3.98%) Volume: 158.32 k 3:58 PM EST Nov 23, 2007
Today 5d 1m 3m 1y more
Last Price
2.35
Change $
0.09
Change %
3.98%
Tick
Bid
2.31
Bid Size
100
Ask
2.35
Ask Size
900
Open
2.22
High
2.38
Low
2.22
Prev Close
2.26
Last Trade
3:58
Volume
158.32 k
52 Wk Hi
4.29
52 Wk Low
1.70
Market Cap
214.69 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
91.36 m
EPS (TTM)
-0.66
PE Ratio
N/A
Exchange
TSX
News for Bioms Medical (MS:CA)
Sector News | Topic News
Fri, Nov 23, 2007
5:00 AM Wall Street Reporter Features Exclusive Video Interviews with CEO's of BioMS Medical Corp., RegeneRx Biopharmaceuticals, Inc., and Canopus BioPharma - PrimeNewswire
Wed, Nov 14, 2007
5:00 PM BioMS Medical announces third quarter 2007 results - PR Newswire
5:00 PM BioMS Medical announces third quarter 2007 results - Canada NewsWire
Mon, Nov 12, 2007
8:02 AM BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial - PR Newswire
8:00 AM BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial - Canada NewsWire
Thu, Nov 08, 2007
8:00 AM BioMS Medical Corp.-Webcast Alert: Biotech/Pharma/Healthcare On-line Forum - CCN Matthews
Wed, Nov 07, 2007
9:13 AM BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board - PR Newswire
9:13 AM BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board - Canada NewsWire
Wed, Oct 31, 2007
7:00 AM BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference - PR Newswire
7:00 AM BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference - Canada NewsWire
More News for MS:CA More Filings for MS:CA

Copyright © QuoteMedia. Data delayed 15 to 20 minutes unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia, fundamentals by Hemscott. Terms of Use.

http://www.wallstreetreporter.com./page.php?page=view_videos&id=१२२

Wall Street Reporter Features Exclusive Video Interviews with ...
CNNMoney.com - USA
The only Phase III study with a novel therapeutic for Secondary Progressive Multiple Sclerosis in the world. * The large patient population and lack of ...
See all stories on this topic

Moving On' from Stigma
Derry Journal - Derry,Northern Ireland,UK
Although, I would not necessarily say this of Primary Progressive MS from which thankfully, I was spared. And to the lady who knocked me and my zimmer frame ...
See all stories on this topic

(MS) Multiple Sclerosis Treatment with Alternative Medicine ...
By gwenniegrelck
By Brent Atwater Montel Williams called it an insidious disease. Richard Pryor passed away with its complications, and Michael Wellford, when diagnosed, just said "I'm NOT having it!" Multiple Sclerosis or MS is a slow progressing ...
the gwennie grelck - http://gwenniegrelck.wealog.com

active biotech's election committee appointed
Genetic Engineering News (press release) - New Rochelle,NY,USA
... advanced projects are laquinimod, an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, ...
See all stories on this topic

Teenage MS sufferer is to be model for national charity
ChronicleLive - Newcastle upon Tyne,England,UK
And the pupil at Gateshead's Thomas Hepburn School is the only person under 18 to try out the MS wonder drug Campath. Patsy lives with her parents, ...
See all stories on this topic

genzyme reports strong earnings growth in third quarter
Oxfordshire Bioscience Network (press release) - Oxford,UK
--the fda approved expanded labeling for campath® (alemtuzumab) to include first-line treatment of b-cell chronic lymphocytic leukemia, ...
See all stories on this topic

posted by Bill at 8:45 PM

0 Comments:

Post a Comment

<< Home